Gaskiya Diagnostics surpasses original fundraising goal of $500K to accelerate
development of its low-cost diagnostic test to detect disease in aquaculture
September 25, 2020, Baltimore, MD – Gaskiya Diagnostics, LLC, a technology company that develops and markets rapid, low-cost and easy-to-use diagnostic tests for aquaculture, announced today that it has closed its first round of seed financing, raising a total of $625,000 while surpassing the company’s original $500,000 fundraising goal.
Gaskiya Diagnostics’ final investment came from Delaware Innovation Space, a multi-dimensional, non-profit incubator and accelerator for start-up companies, via its First Fund program for science and technology-focused startup companies.
Gaskiya Diagnostics serves the $250 billion/year aquaculture industry by enabling farmers to quickly diagnose disease in their stock and take immediate action to mitigate its impact. No specialized training or equipment are needed to perform the tests, making them broadly accessible to farmers of all skill sets. Rapid diagnosis leads to faster treatment, fewer losses and more quality food to meet global demand.
"Aquafarmers in the US and across the globe are looking for a way to rapidly detect disease in their crops,” said Elan Lowenstein, Director of Business Development with Gaskiya Diagnostics. "In closing our first round of seed financing, we’re positioned to accelerate development of our core product and get our easy-to-use diagnostic tests in the hands of aquafarmers."
About Gaskiya Diagnostics:
Gaskiya Diagnostics, LLC is a technology company that develops rapid, low-cost and easy-to-use diagnostic tests for aquaculture. Gaskiya Diagnostics is a portfolio company with Early Charm Ventures. Learn more: www.gaskiyadiagnostics.com